SEC v. Thomas J. Moore, III — U.S. Securities and Exchange Commission Litigation Release No. 26663, dated October 1, 2026.
The SEC charged Thomas J. Moore, III with defrauding approximately 20 investors out of $4.94 million in a medical marijuana business scheme. Moore allegedly misappropriated about $1.94 million for personal expenses and failed to disclose lawsuits and pay promised distributions.
Imagine you invest in a friend's new business, like a cool plant shop. You give them money expecting them to use it to buy plants and supplies. Instead, your friend takes a big chunk of your money and buys fancy clothes and goes on vacation, not for the shop, but for themselves. They also promised you a share of the profits soon, but never paid you, and didn't tell you other people had already sued them for doing the same thing. That's what the SEC says happened here.
Disclaimer: all facts are drawn from the SEC's own filings; the claims described are allegations unless and until a court rules or the parties settle, and some cases end in dismissal.
The SEC charged Thomas J. Moore, III with violating federal securities laws by misappropriating investor funds and making material misstatements and omissions in connection with a medical marijuana business investment scheme. The SEC seeks permanent injunctions, disgorgement with prejudgment interest, and a civil penalty.